- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-12-mer
- Ligands
- 12 x YMZ: (11R,12S)- Mefloquine(Non-covalent)
- 84 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
MC3.2: 5 residues within 4Å:- Chain A: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.3: 8 residues within 4Å:- Chain A: I.73, R.77, Y.78, F.81, L.220
- Chain F: E.249, V.252, F.253
Ligand excluded by PLIPMC3.4: 7 residues within 4Å:- Chain A: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.5: 2 residues within 4Å:- Chain A: F.81
- Ligands: MC3.48
Ligand excluded by PLIPMC3.6: 9 residues within 4Å:- Chain A: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.7
Ligand excluded by PLIPMC3.7: 2 residues within 4Å:- Chain A: V.255
- Ligands: MC3.6
Ligand excluded by PLIPMC3.8: 11 residues within 4Å:- Chain A: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain B: F.81, M.85, T.88
- Ligands: MC3.13
Ligand excluded by PLIPMC3.10: 5 residues within 4Å:- Chain B: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.11: 8 residues within 4Å:- Chain A: E.249, V.252, F.253
- Chain B: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.12: 7 residues within 4Å:- Chain B: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.13: 2 residues within 4Å:- Chain B: F.81
- Ligands: MC3.8
Ligand excluded by PLIPMC3.14: 9 residues within 4Å:- Chain B: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.15
Ligand excluded by PLIPMC3.15: 2 residues within 4Å:- Chain B: V.255
- Ligands: MC3.14
Ligand excluded by PLIPMC3.16: 11 residues within 4Å:- Chain B: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain C: F.81, M.85, T.88
- Ligands: MC3.21
Ligand excluded by PLIPMC3.18: 5 residues within 4Å:- Chain C: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.19: 8 residues within 4Å:- Chain B: E.249, V.252, F.253
- Chain C: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.20: 7 residues within 4Å:- Chain C: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.21: 2 residues within 4Å:- Chain C: F.81
- Ligands: MC3.16
Ligand excluded by PLIPMC3.22: 9 residues within 4Å:- Chain C: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.23
Ligand excluded by PLIPMC3.23: 2 residues within 4Å:- Chain C: V.255
- Ligands: MC3.22
Ligand excluded by PLIPMC3.24: 11 residues within 4Å:- Chain C: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain D: F.81, M.85, T.88
- Ligands: MC3.29
Ligand excluded by PLIPMC3.26: 5 residues within 4Å:- Chain D: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.27: 8 residues within 4Å:- Chain C: E.249, V.252, F.253
- Chain D: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.28: 7 residues within 4Å:- Chain D: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.29: 2 residues within 4Å:- Chain D: F.81
- Ligands: MC3.24
Ligand excluded by PLIPMC3.30: 9 residues within 4Å:- Chain D: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.31
Ligand excluded by PLIPMC3.31: 2 residues within 4Å:- Chain D: V.255
- Ligands: MC3.30
Ligand excluded by PLIPMC3.32: 11 residues within 4Å:- Chain D: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain E: F.81, M.85, T.88
- Ligands: MC3.37
Ligand excluded by PLIPMC3.34: 5 residues within 4Å:- Chain E: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.35: 8 residues within 4Å:- Chain D: E.249, V.252, F.253
- Chain E: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.36: 7 residues within 4Å:- Chain E: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.37: 2 residues within 4Å:- Chain E: F.81
- Ligands: MC3.32
Ligand excluded by PLIPMC3.38: 9 residues within 4Å:- Chain E: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.39
Ligand excluded by PLIPMC3.39: 2 residues within 4Å:- Chain E: V.255
- Ligands: MC3.38
Ligand excluded by PLIPMC3.40: 11 residues within 4Å:- Chain E: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain F: F.81, M.85, T.88
- Ligands: MC3.45
Ligand excluded by PLIPMC3.42: 5 residues within 4Å:- Chain F: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.43: 8 residues within 4Å:- Chain E: E.249, V.252, F.253
- Chain F: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.44: 7 residues within 4Å:- Chain F: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.45: 2 residues within 4Å:- Chain F: F.81
- Ligands: MC3.40
Ligand excluded by PLIPMC3.46: 9 residues within 4Å:- Chain F: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.47
Ligand excluded by PLIPMC3.47: 2 residues within 4Å:- Chain F: V.255
- Ligands: MC3.46
Ligand excluded by PLIPMC3.48: 11 residues within 4Å:- Chain A: F.81, M.85, T.88
- Chain F: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Ligands: MC3.5
Ligand excluded by PLIPMC3.50: 5 residues within 4Å:- Chain G: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.51: 8 residues within 4Å:- Chain G: I.73, R.77, Y.78, F.81, L.220
- Chain L: E.249, V.252, F.253
Ligand excluded by PLIPMC3.52: 7 residues within 4Å:- Chain G: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.53: 2 residues within 4Å:- Chain G: F.81
- Ligands: MC3.96
Ligand excluded by PLIPMC3.54: 9 residues within 4Å:- Chain G: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.55
Ligand excluded by PLIPMC3.55: 2 residues within 4Å:- Chain G: V.255
- Ligands: MC3.54
Ligand excluded by PLIPMC3.56: 11 residues within 4Å:- Chain G: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain H: F.81, M.85, T.88
- Ligands: MC3.61
Ligand excluded by PLIPMC3.58: 5 residues within 4Å:- Chain H: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.59: 8 residues within 4Å:- Chain G: E.249, V.252, F.253
- Chain H: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.60: 7 residues within 4Å:- Chain H: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.61: 2 residues within 4Å:- Chain H: F.81
- Ligands: MC3.56
Ligand excluded by PLIPMC3.62: 9 residues within 4Å:- Chain H: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.63
Ligand excluded by PLIPMC3.63: 2 residues within 4Å:- Chain H: V.255
- Ligands: MC3.62
Ligand excluded by PLIPMC3.64: 11 residues within 4Å:- Chain H: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain I: F.81, M.85, T.88
- Ligands: MC3.69
Ligand excluded by PLIPMC3.66: 5 residues within 4Å:- Chain I: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.67: 8 residues within 4Å:- Chain H: E.249, V.252, F.253
- Chain I: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.68: 7 residues within 4Å:- Chain I: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.69: 2 residues within 4Å:- Chain I: F.81
- Ligands: MC3.64
Ligand excluded by PLIPMC3.70: 9 residues within 4Å:- Chain I: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.71
Ligand excluded by PLIPMC3.71: 2 residues within 4Å:- Chain I: V.255
- Ligands: MC3.70
Ligand excluded by PLIPMC3.72: 11 residues within 4Å:- Chain I: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain J: F.81, M.85, T.88
- Ligands: MC3.77
Ligand excluded by PLIPMC3.74: 5 residues within 4Å:- Chain J: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.75: 8 residues within 4Å:- Chain I: E.249, V.252, F.253
- Chain J: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.76: 7 residues within 4Å:- Chain J: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.77: 2 residues within 4Å:- Chain J: F.81
- Ligands: MC3.72
Ligand excluded by PLIPMC3.78: 9 residues within 4Å:- Chain J: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.79
Ligand excluded by PLIPMC3.79: 2 residues within 4Å:- Chain J: V.255
- Ligands: MC3.78
Ligand excluded by PLIPMC3.80: 11 residues within 4Å:- Chain J: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain K: F.81, M.85, T.88
- Ligands: MC3.85
Ligand excluded by PLIPMC3.82: 5 residues within 4Å:- Chain K: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.83: 8 residues within 4Å:- Chain J: E.249, V.252, F.253
- Chain K: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.84: 7 residues within 4Å:- Chain K: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.85: 2 residues within 4Å:- Chain K: F.81
- Ligands: MC3.80
Ligand excluded by PLIPMC3.86: 9 residues within 4Å:- Chain K: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.87
Ligand excluded by PLIPMC3.87: 2 residues within 4Å:- Chain K: V.255
- Ligands: MC3.86
Ligand excluded by PLIPMC3.88: 11 residues within 4Å:- Chain K: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Chain L: F.81, M.85, T.88
- Ligands: MC3.93
Ligand excluded by PLIPMC3.90: 5 residues within 4Å:- Chain L: T.248, T.251, V.252, V.255, F.256
Ligand excluded by PLIPMC3.91: 8 residues within 4Å:- Chain K: E.249, V.252, F.253
- Chain L: I.73, R.77, Y.78, F.81, L.220
Ligand excluded by PLIPMC3.92: 7 residues within 4Å:- Chain L: Y.78, L.209, G.212, F.213, G.216, F.219, L.220
Ligand excluded by PLIPMC3.93: 2 residues within 4Å:- Chain L: F.81
- Ligands: MC3.88
Ligand excluded by PLIPMC3.94: 9 residues within 4Å:- Chain L: F.223, S.224, T.251, V.255, F.258, A.259, G.262, I.263
- Ligands: MC3.95
Ligand excluded by PLIPMC3.95: 2 residues within 4Å:- Chain L: V.255
- Ligands: MC3.94
Ligand excluded by PLIPMC3.96: 11 residues within 4Å:- Chain G: F.81, M.85, T.88
- Chain L: V.29, V.30, F.33, F.256, A.259, V.260, I.263
- Ligands: MC3.53
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cho, H.J. et al., Mefloquine-induced conformational shift in Cx36 N-terminal helix leading to channel closure mediated by lipid bilayer. Nat Commun (2024)
- Release Date
- 2024-11-06
- Peptides
- Gap junction delta-2 protein: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-12-mer
- Ligands
- 12 x YMZ: (11R,12S)- Mefloquine(Non-covalent)
- 84 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cho, H.J. et al., Mefloquine-induced conformational shift in Cx36 N-terminal helix leading to channel closure mediated by lipid bilayer. Nat Commun (2024)
- Release Date
- 2024-11-06
- Peptides
- Gap junction delta-2 protein: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L - Membrane
-
We predict this structure to be a membrane protein.